CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
of Best Available Therapy (BAT) for treatment-resistant relapsing multiple sclerosis (MS). Participants will be randomized...
Phase 3
Saint Louis, Missouri, United States and 18 other locations
Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis...
Phase 3
Saint Louis, Missouri, United States and 72 other locations
will evaluate the pharmacokinetics, safety and tolerability, and immunogenicity of ocrelizumab administered subcutaneously to participants with multiple...
Phase 1
Saint Louis, Missouri, United States and 20 other locations
with fingolimod in children and adolescents with relapsing-remitting multiple sclerosis aged between 10 and < 18 years over a durat...
Phase 3
Saint Louis, Missouri, United States and 118 other locations
system (CNS) and blood biomarkers relevant in the relapsing forms of multiple sclerosis (RMS; to include relapsing-remitting MS...
Phase 4
Saint Louis, Missouri, United States and 4 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Saint Louis, Missouri, United States and 208 other locations
The primary objectives are to investigate the safety and tolerability of BIIB091 monotherapy in participants with relapsing multiple sclerosis...
Phase 2
Saint Louis, Missouri, United States and 70 other locations
and adolescents ages ≥ 10 to ≤ 18 years with relapsing-remitting multiple sclerosis (RRMS). The data from this study will serve to ...
Phase 2
Saint Louis, Missouri, United States and 11 other locations
The purpose of this study is to evaluate the safety, tolerability, efficacy, and drug levels of CC-97540 in participants with Relapsing Forms of Multiple...
Phase 1
Saint Louis, Missouri, United States and 34 other locations
for the overall conduct of the study at the site, confirmation of subject eligibility, routine study subject clinical management including for MS...
Phase 3
Saint Louis, Missouri, United States and 60 other locations
Clinical trials
Research sites
Resources
Legal